These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18049993)

  • 1. Approaches to acrylamide physiologically based toxicokinetic modeling for exploring child-adult dosimetry differences.
    Walker K; Hattis D; Russ A; Sonawane B; Ginsberg G
    J Toxicol Environ Health A; 2007 Dec; 70(24):2033-55. PubMed ID: 18049993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies of the influence of glutathione transferases and epoxide hydrolase on the detoxification of acrylamide and glycidamide in blood.
    Paulsson B; Rannug A; Henderson AP; Golding BT; Törnqvist M; Warholm M
    Mutat Res; 2005 Feb; 580(1-2):53-9. PubMed ID: 15668107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modifying effect of CYP2E1, GST, and mEH genotypes on the formation of hemoglobin adducts of acrylamide and glycidamide in workers exposed to acrylamide.
    Huang YF; Chiang SY; Liou SH; Chen ML; Chen MF; Uang SN; Wu KY
    Toxicol Lett; 2012 Nov; 215(2):92-9. PubMed ID: 23069881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of PBTK model and biomarker based estimates of the internal dosimetry of acrylamide.
    DeWoskin RS; Sweeney LM; Teeguarden JG; Sams R; Vandenberg J
    Food Chem Toxicol; 2013 Aug; 58():506-21. PubMed ID: 23707562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of acrylamide to glycidamide and their cytotoxicity in isolated rat hepatocytes: protective effects of GSH precursors.
    Kurebayashi H; Ohno Y
    Arch Toxicol; 2006 Dec; 80(12):820-8. PubMed ID: 16699760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP-CERHR monograph on the potential human reproductive and developmental effects of acrylamide.
    National Toxicology Program
    NTP CERHR MON; 2005 Feb; (14):v-I-2, II-xi-166, III-1-74. PubMed ID: 15995732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.
    Doroshyenko O; Fuhr U; Kunz D; Frank D; Kinzig M; Jetter A; Reith Y; Lazar A; Taubert D; Kirchheiner J; Baum M; Eisenbrand G; Berger FI; Bertow D; Berkessel A; Sörgel F; Schömig E; Tomalik-Scharte D
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):433-43. PubMed ID: 19190172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a physiologically-based toxicokinetic model of acrylamide and glycidamide in rats and humans.
    Sweeney LM; Kirman CR; Gargas ML; Carson ML; Tardiff RG
    Food Chem Toxicol; 2010 Feb; 48(2):668-85. PubMed ID: 19948202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide.
    Tareke E; Twaddle NC; McDaniel LP; Churchwell MI; Young JF; Doerge DR
    Toxicol Appl Pharmacol; 2006 Nov; 217(1):63-75. PubMed ID: 17007897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes.
    Duale N; Bjellaas T; Alexander J; Becher G; Haugen M; Paulsen JE; Frandsen H; Olesen PT; Brunborg G
    Toxicol Sci; 2009 Mar; 108(1):90-9. PubMed ID: 19131562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The garlic ingredient diallyl sulfide inhibits cytochrome P450 2E1 dependent bioactivation of acrylamide to glycidamide.
    Taubert D; Glöckner R; Müller D; Schömig E
    Toxicol Lett; 2006 Jun; 164(1):1-5. PubMed ID: 16337756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies of the influence of certain enzymes on the detoxification of acrylamide and glycidamide in blood.
    Paulsson B; Warholm M; Rannug A; Törnqvist M
    Adv Exp Med Biol; 2005; 561():127-33. PubMed ID: 16438295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic consequences of paternal acrylamide exposure and potential for amelioration.
    Katen AL; Roman SD
    Mutat Res; 2015 Jul; 777():91-100. PubMed ID: 25989052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect.
    Ghanayem BI; Witt KL; Kissling GE; Tice RR; Recio L
    Mutat Res; 2005 Oct; 578(1-2):284-97. PubMed ID: 15982677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of safe dietary intake levels of acrylamide for humans.
    Tardiff RG; Gargas ML; Kirman CR; Carson ML; Sweeney LM
    Food Chem Toxicol; 2010 Feb; 48(2):658-67. PubMed ID: 19948203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A physiologically based pharmacokinetic model for acrylamide and its metabolite, glycidamide, in the rat.
    Kirman CR; Gargas ML; Deskin R; Tonner-Navarro L; Andersen ME
    J Toxicol Environ Health A; 2003 Feb; 66(3):253-74. PubMed ID: 12521671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicokinetics of acrylamide and glycidamide in B6C3F1 mice.
    Doerge DR; Young JF; McDaniel LP; Twaddle NC; Churchwell MI
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):258-67. PubMed ID: 15667831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile of human cells in culture exposed to glycidamide, a reactive metabolite of the heat-induced food carcinogen acrylamide.
    Clement FC; Dip R; Naegeli H
    Toxicology; 2007 Oct; 240(1-2):111-24. PubMed ID: 17822822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat.
    Bergmark E; Calleman CJ; Costa LG
    Toxicol Appl Pharmacol; 1991 Nov; 111(2):352-63. PubMed ID: 1957318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity.
    Fuhr U; Boettcher MI; Kinzig-Schippers M; Weyer A; Jetter A; Lazar A; Taubert D; Tomalik-Scharte D; Pournara P; Jakob V; Harlfinger S; Klaassen T; Berkessel A; Angerer J; Sörgel F; Schömig E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):266-71. PubMed ID: 16492914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.